LEVERAGING INFILTRATING MYELOID CELLS TO IMPROVE THERAPEUTIC RESPONSE TO BITE- SECRETING T CELLS IN OVARIAN CANCER
$929,806FY2025Defense Health AgencyDOD
Health Research, Inc., Rockville MD
Investigators
View source on USAspending →LEVERAGING INFILTRATING MYELOID CELLS TO IMPROVE THERAPEUTIC RESPONSE TO BITE- SECRETING T CELLS IN OVARIAN CANCER · GrantIndex